Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Jimenez

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Insights Into Imaging|June 2, 2026
Correction: Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decisionAndreu Antolin, Richard Mast, Nuria Roson, et al.
Insights Into Imaging|April 25, 2026
Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decisionAndreu Antolin, Richard Mast, Nuria Roson, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
Cancer Discovery|August 23, 2019
ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem CellsAna Jimenez-Pascual, James S Hale, Anja Kordowski, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 12, 2022
Circadian clock gene variants and their link with chronotype, chrononutrition, sleeping patterns and obesity in the European prospective investigation into cancer and nutrition (EPIC) studyEsther Molina-Montes, Miguel Rodríguez-Barranco, Ana Ching-López, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 6, 2025
Nutritional profile of the diet according to circadian clock genes in the European Prospective Investigation into Cancer and Nutrition (EPIC) chronodiet studyEsther Molina-Montes, Miguel Rodríguez-Barranco, Ángela Alcalá-Santiago, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Antimicrobial Chemotherapy|February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceChristopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsChristopher A Darlow, Laura McEntee, Adam Johnson, et al.
Insights Into Imaging|June 2, 2026
Correction: Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decisionAndreu Antolin, Richard Mast, Nuria Roson, et al.
Insights Into Imaging|April 25, 2026
Combined radiomics, PI-RADS, and clinical model improve significant prostate cancer prediction and guide biopsy decisionAndreu Antolin, Richard Mast, Nuria Roson, et al.
Frontiers in Oncology|March 10, 2025
Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohortJose Lozano-Montoya, Ana Jimenez-Pastor, Almudena Fuster-Matanzo, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
Cancer Discovery|August 23, 2019
ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem CellsAna Jimenez-Pascual, James S Hale, Anja Kordowski, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 12, 2022
Circadian clock gene variants and their link with chronotype, chrononutrition, sleeping patterns and obesity in the European prospective investigation into cancer and nutrition (EPIC) studyEsther Molina-Montes, Miguel Rodríguez-Barranco, Ana Ching-López, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceChristopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Clinical Nutrition (Edinburgh, Scotland)|May 6, 2025
Nutritional profile of the diet according to circadian clock genes in the European Prospective Investigation into Cancer and Nutrition (EPIC) chronodiet studyEsther Molina-Montes, Miguel Rodríguez-Barranco, Ángela Alcalá-Santiago, et al.
Pageof 13